Patria Investments Announces Partnership with Bancolombia to Continue Latin American Expansion

Joint venture with Bancolombia expands Patria’s real estate capabilities into Colombia adding $1 billion of AUM, and will leverage a strong distribution platform to offer a full suite of alternative investment products to Colombian investors

GRAND CAYMAN, Cayman Islands, July 05, 2023 (GLOBE NEWSWIRE) — Patria Investments (“Patria”) (NASDAQ: PAX), a global alternative asset manager, announced today an agreement for the formation of a joint venture with Bancolombia, the leading full-service financial conglomerate incorporated in Colombia, with more than 148 years of experience serving clients in Colombia and Central America. The partnership will leverage Patria’s extensive private markets expertise in Latin America with Bancolombia’s well-established distribution capabilities to further expand access to alternative investment products in Colombia. At its inception, the JV will manage a permanent capital real estate investment vehicle with approximately US$1 billion of assets under management, which is the second largest fund in Colombia and focused broadly across market sectors.

“We’re very excited to announce this partnership with Bancolombia, which continues our efforts to build comprehensive local asset management practices that can provide investors with tailored alternatives products in their local currencies, as well as access to Patria’s suite of existing regional products” said Alex Saigh, Patria’s CEO. “Patria is already an established investor in Colombia through our private equity and infrastructure funds, and joining with a leading brand and distribution partner gives us a more complete presence in the country.”

The Colombian long-term savings market totals approximately US$145 billion, which has supported the growth and evolution of a US$10+ billion alternative asset management industry providing investment solutions for mandatory & voluntary pensions, life insurance companies, and private investors. Patria’s 35-year expertise in identifying, designing, and managing long-term investment solutions for institutional and private investors, together with Bancolombia’s leading position in the financial industry and developed distribution network, will allow this joint venture to provide innovative solutions to foster the local alternative asset management industry and drive long-term growth for clients.

The creation of a new company in alliance with Patria Investments will allow us to evolve the Colombian alternative asset market, and boost our value proposition for our clients to include world-class investment solutions in Colombia” said Juan Carlos Mora, Bancolombia’s CEO.

Transaction Overview

While specific financial details of the transaction are not being disclosed, the joint venture will be structured with 51% ownership by Patria and 49% by Bancolombia, with approximately $1 billion of Fee Earning AUM at inception. Patria will contribute capital to be deployed over multiple years to support joint venture operations, as well as to fund GP commitments to promote growth of the existing real estate investment vehicle and new funds within other asset classes. The transaction is expected to close during Q3 2023, and expected to be accretive to Patria’s Fee Related Earnings and Distributable Earnings from day one.

Patria’s management team will be available to discuss the transaction on Patria’s upcoming 2nd quarter 2023 earnings call.

About Patria Investments

Patria is a leading alternative investment firm focused on Latin America, with over 35 years of history and combined assets under management of $27.3 billion, and a global presence with offices in 10 cities across 4 continents. Patria aims to provide consistent returns in attractive long term investment opportunities that allow for portfolio diversification through its Private Equity, Infrastructure, Credit, Public Equities and Real Estate products. Through its investments Patria seeks to transform industries generating attractive returns for its investors, while creating sustainable value for society.

Further information is available at www.patria.com.

About Bancolombia

Grupo Bancolombia is a financial group with 148 years of experience that operates in Colombia and Central America, serving more than 29 million clients with financial and non-financial products and services. It includes a full range of banking solutions, trading, trust, asset management, leasing, factoring, and investment banking, among others. To generate a positive impact in the community, the organization is driven by its purpose of promoting sustainable economic development to achieve everyone´s well-being. Grupo Bancolombia delivers its products and services via its regional network comprised of Colombia’s largest non-government owned banking network, El Salvador’s leading financial conglomerate (Banagricola S.A.), International banking and local (Banistmo S.A.) banking subsidiaries in Panama, Guatemala, Cayman and Puerto Rico.

Disclaimer:

This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any securities of Patria Investments Limited. The information contained herein does not purport to be all-inclusive. The data contained herein is derived from various internal and external sources. Any estimates or projections included should not be relied upon as being necessarily indicative of future results.

Forward Looking Statements:

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify these forward-looking statements by the use of words such as “outlook,” “indicator,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “could,” “would,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. We believe these factors include but are not limited to those described under the section entitled “Risk Factors” in our annual report on Form 20-F for the year ended December 31, 2021, as such factors may be updated from time to time in our periodic filings with the United States Securities and Exchange Commission (“SEC”), which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in our periodic filings. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date of this investor presentation. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, and if we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. There can be no assurance that the proposed transactions described in this presentation, which are subject to certain closing conditions, will be completed, nor can there be any assurance, if the transactions are completed, that any potential benefits of the transactions will be realized. The description of the transactions contained herein is only a summary and does not purport to be complete.

Press service:

Brazil – Ideal H+K Strategies (

[email protected]

)

Rodrigo Fonseca: +55 11 9.4846-5003 / [email protected]

Patria Shareholder Relations:

Josh Wood: +1 917 769 1611 / [email protected]



ReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible Beneficiaries

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced that it will host a conference call and webcast on Tuesday, July 11, 2023 to discuss the recent proposal from the Centers for Medicare & Medicaid Services (“CMS”) to include personal exoskeletons in the Medicare benefit category for braces as part of the Calendar Year 2024 Home Health Prospective Payment System Proposed Rule, CMS-1780-P (“Proposed Rule”), released on June 30, 2023.

The Proposed Rule would establish a regulatory definition of “brace” and specify that exoskeletons like the ReWalk Personal Exoskeleton fit in this definition. Once finalized, the Medicare benefit category for personal exoskeletons would be clear – i.e., the Medicare benefit category for “leg, arm, back, and neck braces” – and payment would be on a lump sum basis. The Proposed Rule has a 60-day comment period ending on Tuesday, August 29 at 5 pm EDT. During the comment period, interested stakeholders can submit comments and feedback on the proposal prior to its expected finalization in early November.

Additional information on the Proposed Rule can be found at https://www.federalregister.gov/public-inspection/2023-14044/medicare-program-calendar-year-2024-home-health-prospective-payment-system-rate-update-home-health, as well as in the Company’s corresponding press release, issued June 30, 2023, at https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-applauds-medicare-proposal-include-personal.

Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast on July 11th at 8:30 a.m. EDT to discuss the potential impact of the Proposed Rule. They will be joined on the call by Jeannine Lynch, Vice President of Strategy and Market Access, and Ashley Barnes, exoskeleton advocate and ReWalk Personal Exoskeleton user since 2015.

To access the call, analysts and investors may utilize the following:

Toll free (U.S.):
International (U.S):
Israel:
Access Code:
1-833-316-0561
1-412-317-0690
1-809-212373
Please reference the “ReWalk Robotics Ltd. Call”
   

The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at rewalk.com in the “Investors” section, or through the following link: https://edge.media-server.com/mmc/p/3dupfmju. An archived webcast will also be available on the Company’s website.

About ReWalk Robotics Ltd.:
ReWalk Robotics Ltd. is a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions. ReWalk’s mission is to fundamentally change the quality of life for these individuals through the creation and development of market leading technologies. Founded in 2001, ReWalk has operations in the United States, Israel, and Germany. For more information on the ReWalk systems, please visit rewalk.com.

ReWalk® and ReStore® are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding ReWalk’s future performance, statements regarding the Proposed Rule and its contents, which are preliminary and subject to further review and revision by CMS prior to publication, the timing for publication and effectiveness of the final rule, and the potential business or regulatory impact of the final rule once published and effective, and other statements that are not statements of historical fact and, in some cases, may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “should,” “would,” “seek” and similar terms or phrases. The forward-looking statements contained in this press release are based on management’s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of ReWalk’s control. Important factors that could cause ReWalk’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in ReWalk’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading “Risk Factors” in ReWalk’s annual report on Forms 10-K and 10-K/A for the year ended December 31, 2022 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause ReWalk’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for ReWalk to predict all of them. Except as required by law, ReWalk undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

ReWalk Media Relations:

John Tomlin
E: [email protected]

ReWalk Investor Contact:

Mike Lawless
Chief Financial Officer
ReWalk Robotics Ltd
E: [email protected]



Stronghold Digital Mining Provides June 2023 Bitcoin Mining Update

NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, the “Company”, or “we”) today provided the following operational update:

Bitcoin Mining

During the month of June, Stronghold was awarded approximately 225 Bitcoin through its mining operations, which, when combined with April and May Bitcoin production, equates to over 626 Bitcoin mined during the second quarter of 2023. This represents approximately 43% growth compared to Bitcoin awards during the fourth quarter of 2022 and 1% sequential growth compared to the first quarter of 2023 despite Bitcoin network hash rate growth of 39% and 23% during the same periods, respectively.

During June 2023, the Company received and energized the 2,000 Avalon 1346 Bitcoin mining rigs associated with its previously announced Canaan Bitcoin Mining Agreement. The Company continues to actively evaluate incremental opportunities, representing over 1 EH/s, to fill its remaining data center slots. While no assurances can be made that Stronghold will be able to consummate any of these transactions, the Company continues to believe that it will be able to fill its existing 4 EH/s of data center capacity by the end of the third quarter of 2023. Beyond the 4 EH/s of data center capacity at the Company’s wholly owned Scrubgrass and Panther Creek plants, Stronghold has extensively evaluated opportunities to deploy its additional 25 MW of end-to-end data center equipment that it owns in inventory, which includes 20 proprietary StrongBox containers and the transformers, breakers, and switchgear to support them. The Company expects to make a decision on the location of a third site for the deployment of the data center equipment during the third quarter of 2023.

About Stronghold Digital Mining, Inc.

Stronghold is a vertically integrated Bitcoin mining company with an emphasis on environmentally beneficial operations. Stronghold houses its miners at its wholly owned and operated Scrubgrass and Panther Creek plants, both of which are low-cost, environmentally beneficial coal refuse power generation facilities in Pennsylvania.

Cautionary Statement Concerning Forward-Looking Statements

Certain statements contained in this press release, including guidance, constitute “forward-looking statements.” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates” or “anticipates” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. Forward-looking statements and the business prospects of Stronghold are subject to a number of risks and uncertainties that may cause Stronghold’s actual results in future periods to differ materially from the forward-looking statements. These risks and uncertainties include, among other things: the hybrid nature of our business model, which is highly dependent on the price of Bitcoin; our dependence on the level of demand and financial performance of the crypto asset industry; our ability to manage growth, business, financial results and results of operations; uncertainty regarding our evolving business model; our ability to retain management and key personnel and the integration of new management; our ability to raise capital to fund business growth; our ability to maintain sufficient liquidity to fund operations, growth and acquisitions; our substantial indebtedness and its effect on our results of operations and our financial condition; uncertainty regarding the outcomes of any investigations or proceedings; our ability to enter into purchase agreements, acquisitions and financing transactions; public health crises, epidemics, and pandemics such as the coronavirus pandemic; our ability to procure crypto asset mining equipment from foreign-based suppliers; our ability to maintain our relationships with our third party brokers and our dependence on their performance; our ability to procure crypto asset mining equipment; developments and changes in laws and regulations, including increased regulation of the crypto asset industry through legislative action and revised rules and standards applied by The Financial Crimes Enforcement Network under the authority of the U.S. Bank Secrecy Act and the Investment Company Act; the future acceptance and/or widespread use of, and demand for, Bitcoin and other crypto assets; our ability to respond to price fluctuations and rapidly changing technology; our ability to operate our coal refuse power generation facilities as planned; our ability to remain listed on a stock exchange and maintain an active trading market; our ability to avail ourselves of tax credits for the clean-up of coal refuse piles; and legislative or regulatory changes, and liability under, or any future inability to comply with, existing or future energy regulations or requirements. More information on these risks and other potential factors that could affect our financial results is included in our filings with the Securities and Exchange Commission, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our Annual Report on Form 10-K filed on April 3, 2023. Any forward-looking statement or guidance speaks only as of the date as of which such statement is made, and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements or guidance, whether because of new information, future events, or otherwise.

Investor Contact:

Matt Glover or Alex Kovtun
Gateway Group, Inc.
[email protected]
1-949-574-3860

Media Contact:

[email protected]



SYLA Technologies’ Rimawari-kun has been Ranked as the Top Real Estate Crowdfunding Platform in Japan for Two Consecutive Years

TOKYO, July 05, 2023 (GLOBE NEWSWIRE) — SYLA Technologies Co., Ltd.(NASDAQ: SYT) (“SYLA” or “the Company”), operator of the largest membership real estate crowd-funding platform in Japan, announced that its Real Estate Crowdfunding Service, Rimawari-kun, has been ranked as the top real estate crowdfunding platform in Japan by total memberships for the second year in a row, according to a market-wide survey performed by the Japan Marketing Research Organization.

Rimawari-kun connects unique and broad real estate project exhibitors and exhibits with investors by way of a unified, and enhanced user experience (UX). Rimawari-kun advertises profit opportunities for investors via yield and social contribution as investments work towards regional revitalization in Japan. As of June 22, 2023, the number of registered members of Rimawari-kun has exceeded 260,000.

Since June 1, 2023, SYLA has been running a campaign and commemorative fund to celebrate the inception anniversary of the Rimawari-kun platform. Furthermore, in July of 2023, the Company plans to launch an additional campaign to commemorate the status as the two year consecutive leader in real estate crowdfunding membership in Japan. Details of this campaign will be announced early in July.

“The announcement of our two-year achievement as the top real estate crowdfunding platform in Japan signals a benchmark moment for our Company,” said SYLA’s Chairman, Founder, and CEO Hiroyuki Sugimoto. “Investors of all wealth-brackets in Japan are increasingly becoming aware of the opportunity our platform has to offer in the realm of real estate investment, and we have delivered steady value to our investors. We look to continue to promote democratization of real estate investment across Japan, and subsequently internationally, through our Rimawari-kun.”

About SYLA Technologies Co., Ltd.

Headquartered in Tokyo, Japan, our company consists of SYLA Technologies Co., Ltd. and its consolidated subsidiaries (SYLA Co., Ltd., SYLA Solar Co., Ltd., SYLA Brain Co., Ltd., and SYLA Biotech Co., Ltd.). The Company owns and operates the largest membership real estate crowd-funding platform in Japan, Rimawari-kun, which targets individuals, corporate and institutional investors, as well as high net worth individuals. Their mission is to democratize real estate investment around the world through technology and asset management through the Rimawari-kun platform. They are engaged in the overall investment condominium business, including planning, development, construction, sales, rental management, building management, repair work, and the sale of properties. Additional information about the Company’s products and services is available at https://syla-tech.jp/en

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected gross proceeds and the closing of the offering. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on Form 20-F, filed with the SEC on April 18, 2023. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

Contact Information

Gateway Group, Inc.
John Yi and Thomas Thayer
[email protected]
Tel +1 (949) 574-3860

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/57cca5bd-6cc2-47c7-bc1d-94efa8bbeb8a



Invitation Homes and Esusu to Provide Free Positive Credit Reporting For Nearly 200,000 Invitation Homes Residents

DALLAS and HARLEM, N.Y., July 05, 2023 (GLOBE NEWSWIRE) — Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes” or the “Company”), the nation’s premier single-family home leasing company, and Esusu, a leading financial technology company advancing rent reporting and data solutions for credit building, today announced a new partnership to make Esusu’s platform for financial health solutions available at no cost to Invitation Homes residents across 80,000+ homes nationwide. This collaboration will provide free positive credit reporting to nearly 200,000 adult residents of Invitation Homes.

Since its inception in 2018, Esusu has empowered millions of renters to enhance their credit scores by reporting on-time rent payments to the three major credit bureaus. This partnership signifies a meaningful step forward in the single-family rental industry and marks one of Esusu’s most significant platform expansions to date.

“We work hard every day to provide an exceptional experience for our residents by offering high-quality homes, excellent service, and amenities that make their lives easier, and this partnership with Esusu extends our commitment to enhancing our residents’ financial well-being,” said Dallas Tanner, CEO of Invitation Homes. “This collaboration reinforces Invitation Homes’ dedication to offering choice and flexibility, and we believe that by providing free positive credit reporting for all of our adult residents we are further removing barriers to housing choice and helping our residents achieve their financial goals.”

“With this collaboration, we believe Esusu and Invitation Homes are forging a path toward financial empowerment by helping dismantle barriers to economic opportunities,” remarked Wemimo Abbey and Samir Goel, Co-Founders of Esusu. “Esusu’s commitment to enhancing the financial well-being of renters drives us to offer transformative credit-building services and a comprehensive platform for financial health. We believe that partnering with Invitation Homes, a long-standing leader in the single-family rental market, enables us to scale Esusu’s vision to bridge the racial wealth gap and positively transform communities nationwide.”

About Esusu

Esusu is the leading financial technology platform that leverages data solutions to empower residents and improve property performance. Esusu’s rent reporting platform captures rental payment data and reports it to credit bureaus to boost credit scores. This allows renters to build and establish their credit scores while helping property owners mitigate against initiating evictions, powered by differentiated data and insights. Founded in 2018, Esusu reaches over 4 million rental units across all 50 states in the United States. Learn more at www.esusurent.com and follow us on Instagram @myesusu and on Twitter @getesusu.

About Invitation Homes

Invitation Homes, an S&P 500 company, is the nation’s premier single-family home leasing company, meeting changing lifestyle demands by providing access to high-quality, updated homes with valued features such as proximity to jobs and access to good schools. The Company’s mission, “Together with you, we make a house a home,” reflects its commitment to providing homes where individuals and families can thrive and high-touch service that continuously enhances residents’ living experiences.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which include, but are not limited to, statements related to the Company’s expectations regarding the performance of the Company’s business, its financial results, its liquidity and capital resources, and other non-historical statements. In some cases, you can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties, including, among others, risks inherent to the single-family rental industry and the Company’s business model, macroeconomic factors beyond the Company’s control, competition in identifying and acquiring properties, competition in the leasing market for quality residents, increasing property taxes, homeowners’ association and insurance costs, poor resident selection and defaults and non-renewals by the Company’s residents, the Company’s dependence on third parties for key services, risks related to the evaluation of properties, performance of the Company’s information technology systems, risks related to the Company’s indebtedness, risks related to the potential negative impact of unfavorable global and United States economic conditions (including inflation and rising interest rates), uncertainty in financial markets (including as a result of recent bank failures and events affecting financial institutions), geopolitical tensions, natural disasters, climate change, and public health crises on the Company’s financial condition, results of operations, cash flows, business, associates, and residents. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The Company believes these factors include, but are not limited to, those described under Part I. Item 1A. “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”), as such factors may be updated from time to time in the Company’s periodic filings with the Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release, in the Annual Report, and in the Company’s other periodic filings. The forward-looking statements speak only as of the date of this press release, and the Company expressly disclaims any obligation or undertaking to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except to the extent otherwise required by law.


Invitation Homes Contacts

Investor Relations:

Scott McLaughlin
Phone: 844.456.INVH (4684)
Email: [email protected]

Media Relations:

Kristi DesJarlais
Phone: 972.421.3587
Email: [email protected]


Esusu Contact

SGPR on behalf of Esusu
[email protected]



GlobalFoundries Announces Conference Call to Review Second Quarter 2023 Financial Results

MALTA, N.Y., July 05, 2023 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Tuesday, August 8, 2023, at 8:30 a.m. ET following the release of the company’s second quarter 2023 financial results.


Conference Call and Webcast Information

The company will host a conference call with the financial community on Tuesday, August 8, 2023, at 8:30 a.m. ET. Interested parties may join the scheduled conference call by registering here.

The company’s financial results and a webcast of the conference call will be available on GlobalFoundries’ Investor Relations website at https://investors.gf.com.


About GF

GlobalFoundries Inc. (GF) is one of the world’s leading semiconductor manufacturers. GF is redefining innovation and semiconductor manufacturing by developing and delivering feature-rich process technology solutions that provide leadership performance in pervasive high growth markets. GF offers a unique mix of design, development and fabrication services. With a talented and diverse workforce and an at-scale manufacturing footprint spanning the U.S., Europe and Asia, GF is a trusted technology source to its worldwide customers. For more information, visit www.gf.com.

©GlobalFoundries Inc. GF, GlobalFoundries, the GF logos and other GF marks are trademarks of GlobalFoundries Inc. or its subsidiaries. All other trademarks are the property of their respective owners.


For further information, please contact:


                 
[email protected]



Designerie Furnishes New Revenue Growth Strategy with HawkSearch

WOBURN, Mass., July 05, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a leader in cloud-based marketing technology software, is proud to announce that Designerie, a premier importer and distributor of European Designer-Focused Furniture, has chosen HawkSearch, Bridgeline’s advanced AI-powered search solution, to drive their ecommerce operations.

The premier importer and distributor of European designer-focused furniture has committed to a 36-month agreement with HawkSearch across two of its websites, Designerie and Sika-Design. They selected HawkSearch for its scalability to additional sites through the BigCommerce connector, advanced merchandising and recommendations capabilities, and ability to work with variant logic, all of which gave it an edge over competitor solutions. Using HawkSearch, websites such as Designerie have experienced an increase of over 50% more traffic, alongside a 20% boost in conversions. Designerie will also utilize HawkSearch’s Rapid UI Framework for fast implementation on its sites powered by BigCommerce MSF (Multi Storefront).

Since 2008, Designerie has been a trusted name in importing and distributing unique, high-quality furniture across the United States and Europe. They are dedicated to providing excellent service and promoting growth in the exclusive furniture market.

Drawing on over a decade of experience serving international distributors such as Valken Sports and Brownells, HawkSearch drives ecommerce growth through AI-powered features like Smart Search, Dynamic Targeting, and accelerated search solution implementation with Rapid UI Framework.

“We’re absolutely delighted to be teaming up with Designerie. They’re a real force to be reckoned with in the designer furniture industry. We’re looking forward to being a part of their digital journey and helping them take their online business to the next level.” Said Ari Kahn, CEO of Bridgeline Digital.

About Bridgeline Digital

Bridgeline Digital assists businesses in boosting their online revenue by increasing traffic, conversion rates, and average order value. To learn more, please visit www.bridgeline.com.

Contact:

Danielle Erwin

SVP of Marketing

Bridgeline Digital


[email protected]





ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced today that leading independent proxy advisor Institutional Shareholder Services Inc. (“ISS”) has recommended that Infinity stockholders vote FOR the merger with MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”).

ISS is an independent proxy advisory firm whose clients include many of the world’s leading institutional investors, and who rely on ISS’s objective and impartial analysis to make important voting decisions.

“We are pleased to receive ISS’s independent recommendation to Infinity stockholders to vote FOR the merger with MEI. The combined company will have an attractive combined clinical pipeline, strong balance sheet, and multiple value creation opportunities for stockholders. We believe stockholders will also benefit from an experienced and well-rounded management team with a strong focus in operational excellence to advance the development of our differentiated clinical candidates,” said Adelene Perkins, Chief Executive Officer, and Chair of Infinity’s board of directors (the “Board”).

ISS’s evaluation and endorsement of the merger with MEI underscores the key potential benefits of the transaction for Infinity stockholders as part of the combined company, including:

  • A robust and differentiated pipeline of three promising clinical-stage oncology drug candidates with initial clinical data on all 3 programs expected by the end of 2024 that we believe position the company for multiple potential near- and long-term value creation events.

  • Approximately $100 million of cash and equivalents projected at the time of the closing that is expected to fund operations through mid-2025, with clinical milestones expected over the next 6 to 24 months.

  • An experienced management team focused on clinical development and operational excellence.

Infinity stockholders, the merger with MEI will provide an exciting value creation opportunity for stockholders of both companies, we need your vote!

Infinity stockholders are reminded to vote their proxies todayFOR” the proposals described in the joint proxy statement and prospectus, prior to the Infinity virtual special meeting of stockholders on July 14, 2023, at 10 a.m. Eastern Time.

Stockholders who have questions about voting their proxy are encouraged to contact Morrow Sodali LLC who are assisting us, at 1-800-662-5200 or [email protected].

About Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies. For more information on Infinity, please refer to Infinity’s website at www.infi.com.

Important Information about the Merger and Where to Find It

This communication relates to a proposed transaction between Infinity) and MEI. In connection with the proposed merger, MEI filed with the SEC a registration statement on Form S-4 that includes a joint proxy statement of MEI and Infinity (the “Joint Proxy Statement/Prospectus) that also constitutes a prospectus of MEI. The registration statement on Form S-4 was declared effective by the SEC on June 6, 2023. MEI and Infinity have each filed and mailed the Joint Proxy Statement/Prospectus to their respective stockholders. INVESTORS AND MEI’S AND INFINITY’S RESPECTIVE STOCKHOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS IN ITS ENTIRETY AND ANY OTHER DOCUMENTS FILED BY EACH OF MEI AND INFINITY WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER OR INCORPORATED BY REFERENCE THEREIN BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND THE PARTIES TO THE PROPOSED MERGER. Investors and stockholders may obtain a free copy of the Joint Proxy Statement/Prospectus and other documents containing important information about MEI and Infinity from the SEC’s website at www.sec.gov. MEI and Infinity make available free of charge at www.meipharma.com and www.infi.com, respectively (in the “Investors” and “Investors/Media” sections, respectively), copies of materials they file with, or furnish to, the SEC.

Participants in the Solicitation

MEI, Infinity and their respective directors, executive officers and certain employees and other persons may be deemed to be participants in the solicitation of proxies from the stockholders of MEI and Infinity in connection with the proposed merger. Securityholders may obtain information regarding the names, affiliations and interests of MEI’s and Infinity’s directors and executive officers in the Joint Proxy Statement/Prospectus which may be obtained free of charge from the SEC’s website at www.sec.gov, MEI’s investor website at https://www.meipharma.com/investors and Infinity’s investor website at https://investors.infi.com/.

No Offer or Solicitation

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements contained in this filing may be considered forward-looking statements within the meaning of the federal securities law. Such statements are based upon current plans, estimates and expectations of the management of MEI and Infinity that are subject to various risks and uncertainties that could cause actual results to differ materially from such statements. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates and expectations will be achieved. Words such as “anticipate,” “expect,” “project,” “intend,” “believe,” “may,” “will,” “should,” “plan,” “could,” “continue,” “target,” “contemplate,” “estimate,” “forecast,” “guidance,” “predict,” “possible,” “potential,” “pursue,” “likely,” and words and terms of similar substance used in connection with any discussion of future plans, actions or events identify forward-looking statements. All statements, other than historical facts, including statements regarding: the expected timing of the closing of the proposed merger; the ability of the parties to complete the proposed merger considering the various closing conditions; the expected benefits of the proposed merger, including estimations of anticipated cost savings and cash runway; the competitive ability and position of the combined company; the potential, safety, efficacy, and regulatory and clinical progress of the combined company’s product candidates, including the anticipated timing for initiation of clinical trials and release of clinical trial data and the expectations surrounding potential regulatory submissions, approvals and timing thereof; the sufficiency of the combined company’s cash, cash equivalents and short-term investments to fund operations; and any assumptions underlying any of the foregoing, are forward-looking statements. Important factors that could cause actual results to differ materially from MEI’s and Infinity’s plans, estimates or expectations could include, but are not limited to: (i) the risk that the proposed merger may not be completed in a timely manner or at all, which may adversely affect MEI’s and Infinity’s businesses and the price of their respective securities; (ii) uncertainties as to the timing of the consummation of the proposed merger and the potential failure to satisfy the conditions to the consummation of the proposed merger, including obtaining stockholder and regulatory approvals; (iii) the proposed merger may involve unexpected costs, liabilities or delays; (iv) the effect of the announcement, pendency or completion of the proposed merger on the ability of MEI or Infinity to retain and hire key personnel and maintain relationships with customers, suppliers and others with whom MEI or Infinity does business, or on MEI’s or Infinity’s operating results and business generally; (v) MEI’s or Infinity’s respective businesses may suffer as a result of uncertainty surrounding the proposed merger and disruption of management’s attention due to the proposed merger; (vi) the outcome of any legal proceedings related to the proposed merger or otherwise, or the impact of the proposed merger thereupon; (vii) MEI or Infinity may be adversely affected by other economic, business, and/or competitive factors; (viii) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement and the proposed merger; (ix) restrictions during the pendency of the proposed merger that may impact MEI’s or Infinity’s ability to pursue certain business opportunities or strategic transactions; (x) the risk that MEI or Infinity may be unable to obtain governmental and regulatory approvals required for the proposed merger, or that required governmental and regulatory approvals may delay the consummation of the proposed merger or result in the imposition of conditions that could reduce the anticipated benefits from the proposed merger or cause the parties to abandon the proposed merger; (xi) risks that the anticipated benefits of the proposed merger or other commercial opportunities may otherwise not be fully realized or may take longer to realize than expected; (xii) the impact of legislative, regulatory, economic, competitive and technological changes; (xiii) risks relating to the value of MEI shares to be issued in the proposed merger; (xiv) the risk that integration of the proposed merger post-closing may not occur as anticipated or the combined company may not be able to achieve the benefits expected from the proposed merger, as well as the risk of potential delays, challenges and expenses associated with integrating the combined company’s existing businesses; (xv) exposure to inflation, currency rate and interest rate fluctuations, as well as fluctuations in the market price of MEI’s and Infinity’s traded securities; (xvi) the impact of the COVID-19 pandemic on MEI’s and Infinity’s industry and individual companies, including on counterparties, the supply chain, the execution of clinical development programs, access to financing and the allocation of government resources; (xvii) final data from pre-clinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; (xviii) costs and delays in the development and/or U.S. Food and Drug Administration (“FDA”) approval, or the failure to obtain such approval, of the combined company’s product candidates; (xix) regulatory authorities may not agree with the design or results of clinical studies and as a result future clinical studies may be subject to holds; (xx) uncertainties or differences in interpretation in clinical trial results; (xxi) the combined company’s inability to maintain or enter into, and the risks resulting from dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any product candidates; and (xxii) the ability of MEI or Infinity to protect and enforce intellectual property rights; and (xxiii) the unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as MEI’s and Infinity’s response to any of the aforementioned factors. Additional factors that may affect the future results of MEI and Infinity are set forth in their respective filings with the United States Securities and Exchange Commission (the “SEC”), including the section entitled “Risk Factors” in the Registration Statement on Form S-4 that was declared effective by the SEC on June 6, 2023 and each of MEI’s and Infinity’s most recently filed Annual Reports on Form 10-K, subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the SEC, which are available on the SEC’s website at www.sec.gov. See in particular MEI’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022 in Part I, Item 1A, “Risk Factors,” and Infinity’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, in Part I, Item 1A, “Risk Factors.” The risks and uncertainties described above and in the SEC filings cited above are not exclusive and further information concerning MEI and Infinity and their respective businesses, including factors that potentially could materially affect their respective businesses, financial conditions or operating results, may emerge from time to time. Readers are urged to consider these factors carefully in evaluating these forward-looking statements, and not to place undue reliance on any forward-looking statements. Any such forward-looking statements represent management’s reasonable estimates and beliefs as of the date of this press release. While MEI and Infinity may elect to update such forward-looking statements at some point in the future, they disclaim any obligation to do so, other than as may be required by law, even if subsequent events cause their views to change.

This press release contains hyperlinks to information that is not deemed to be incorporated by reference.

Infinity

Melissa Hackel

Tel: 617-453-1117

Morrow Sodali, LLC

Tel: (800) 662-5200

[email protected]

KEYWORDS: Massachusetts United States North America Canada

INDUSTRY KEYWORDS: Research Banking General Health Professional Services Pharmaceutical Oncology Clinical Trials Science Biotechnology Finance Other Science Health

MEDIA:

Logo
Logo

Sarepta Therapeutics Announces Sale of Priority Review Voucher for $102 million

Sarepta Therapeutics Announces Sale of Priority Review Voucher for $102 million

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced it had completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV). Sarepta received a payment of $102 million upon completion of the sale.

Sarepta was awarded the PRV following U.S. Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.

Under the Rare Pediatric Disease Priority Review Voucher Program, FDA awards priority review vouchers to sponsors of rare pediatric disease product applications that meet certain criteria. The program is intended to encourage development of new drugs and biologics for the prevention and treatment of rare pediatric diseases. PRVs can be redeemed to receive priority review of a subsequent marketing application for a different product, sold or transferred.

Sarepta will invest proceeds from the sale of the PRV into our R&D efforts to support the development of more transformative therapies.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.comor follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the ‘For Investors’ section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Forward-Looking Statements

This press release contains “forward-looking statements.” Any statements that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “believe,” “anticipate,” “plan,” “expect,” “will,” “may,” “intend,” “prepare,” “look,” “potential,” “possible” and similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to our future operations, business plans, priorities, and research and development programs, including the use of the proceeds from the sale.

These forward-looking statements involve risks and uncertainties, many of which are beyond our control. Actual results could materially differ from those stated or implied by these forward-looking statements as a result of such risks and uncertainties. Known risk factors include the following: the possible impact of regulations and regulatory decisions by the FDA and other regulatory agencies on our business, as well as the development of our product candidates and our financial and contractual obligations; the commencement and completion of our clinical trials and announcement of results may be delayed or prevented for a number of reasons, including, among others, denial by the regulatory agencies of permission to proceed with our clinical trials, or placement of a clinical trial on hold, challenges in identifying, recruiting, enrolling and retaining patients to participate in clinical trials and inadequate quantity or quality of supplies of a product candidate or other materials necessary to conduct clinical trials; we may not be able to execute on our business plans, including meeting our expected or planned regulatory milestones and timelines, research and clinical development plans, and bringing our product candidates to market, for various reasons, many of which may be outside of our control, including possible limitations of company financial and other resources, manufacturing limitations that may not be anticipated or resolved for in a timely manner, regulatory, court or agency decisions, such as decisions by the United States Patent and Trademark Office with respect to patents that cover our product candidates, and the ongoing COVID-19 pandemic; and those risks identified under the heading “Risk Factors” in our most recent Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission (SEC) as well as other SEC filings made by the Company which you are encouraged to review.

Any of the foregoing risks could materially and adversely affect the Company’s business, results of operations and the trading price of Sarepta’s common stock. For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review the SEC filings made by Sarepta. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law.

Investor Contact:

Ian Estepan, 617-274-4052

[email protected]

Media Contact:

Tracy Sorrentino, 617-301-8566

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Health FDA Genetics Clinical Trials

MEDIA:

Logo
Logo

Capital Power Secures 1 GW Supply of Responsibly Produced, Ultra-Low Carbon First Solar Modules

Capital Power Secures 1 GW Supply of Responsibly Produced, Ultra-Low Carbon First Solar Modules

Series 6 Plus thin film modules to power US and Canada projects, with deliveries from 2026 to 2028

TEMPE, Ariz.–(BUSINESS WIRE)–First Solar, Inc. (NASDAQ: FSLR) and Capital Power Corporation (“Capital Power” or “the Company”) (TSX: CPX) announced today that Capital Power has secured its first order for approximately 1 gigawatt (GWDC) of responsibly produced, ultra-low carbon thin film solar modules. The Series 6 Plus modules, which will be delivered between 2026 and 2028, will support Capital Power’s growing development portfolio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230705120066/en/

First Solar and Capital Power Corporation announced today that Capital Power has secured its first order for approximately 1 gigawatt (GWDC) of responsibly produced, ultra-low carbon thin film solar modules. (Photo: Business Wire)

First Solar and Capital Power Corporation announced today that Capital Power has secured its first order for approximately 1 gigawatt (GWDC) of responsibly produced, ultra-low carbon thin film solar modules. (Photo: Business Wire)

“We are excited to partner with First Solar and its responsibly produced ultra-low carbon solar technology, which supports our solar development pipeline,” said Chris Kopecky, Senior Vice President and Chief Legal, Development and Commercial Officer, Capital Power. “First Solar’s longstanding investment in domestic supply chains ensures the use of high-quality American solar technology, including products made with significant amounts of domestically sourced content, to power our projects. Together, with our shared commitment to the sustainable and responsible development of the solar industry, we look forward to building on this relationship.”

First Solar’s responsibly produced, advanced thin film photovoltaic (PV) modules set industry benchmarks for quality, durability, reliability, design, and environmental performance. The company’s solar modules have the lowest carbon and water footprint of any commercially available PV module today, and it’s the first PV manufacturer to have its product included in the Electronic Product Environmental Assessment Tool (EPEAT) global registry for sustainable electronics.

First Solar’s differentiated thin film semiconductor, integrated manufacturing process and tightly controlled supply chain helps eliminate the risk of exposure to solar supply chains identified by the US Department of Labor’s 2022 List of Goods Produced by Child Labor or Forced Labor as being tainted by forced labor. The company is the only one of the world’s ten largest solar manufacturers to be a member of the Responsible Business Alliance (RBA), the world’s largest industry coalition dedicated to supporting the rights and well-being of workers and communities in the global supply chain, and the company has zero tolerance for forced labor in its manufacturing or its supply chains.

“Capital Power joins a growing group of project developers that partner with First Solar as a reliable module technology provider that can help de-risk their project pipelines by delivering long-term pricing and supply certainty,” said Georges Antoun, chief commercial officer, First Solar. “We are pleased that Capital Power selected Responsible Solar technology to power its assets reliably, affordably and sustainably.”

Committed to net zero by 2045, Capital Power’s balanced approach to power generation includes a focused effort on solar energy growth across North America. With three solar facilities in operation, Capital Power will use its development and construction expertise to deliver projects against an active US solar pipeline totaling nearly 2.4 GWDC.

First Solar is investing approximately $1.3 billion in expanding its US manufacturing footprint from over 6.5 gigawatts (GWDC) of annual nameplate capacity currently, to approximately 10.9 GWDC by 2026. In addition to the $1.1 billion expected investment in a new 3.5 GWDC facility in Alabama, the company has also embarked on a $185 million expansion of its existing manufacturing footprint in Ohio. First Solar, the largest solar manufacturer in the Western Hemisphere, also announced an investment of up to $370 million for a dedicated research and development (R&D) innovation center in Perrysburg, Ohio, which is expected to be completed in 2024.

About Capital Power

Capital Power (TSX: CPX) is a growth-oriented North American wholesale power producer with a strategic focus on sustainable energy headquartered in Edmonton, Alberta. We build, own, and operate high-quality, utility-scale generation facilities that include renewables and thermal. We have also made significant investments in carbon capture and utilization to reduce carbon impacts. Capital Power owns approximately 7,500 MW of power generation capacity at 29 facilities across North America. Projects in advanced development include 224 MW of renewable generation in Alberta and North Carolina, 512 MW of incremental natural gas combined cycle capacity from the repowering of Genesee 1 and 2 in Alberta, and approximately 350 MW of natural gas and battery energy storage systems in Ontario.

About First Solar, Inc.

First Solar is a leading American solar technology company and global provider of responsibly produced eco-efficient solar modules advancing the fight against climate change. Developed at R&D labs in California and Ohio, the company’s advanced thin film photovoltaic (PV) modules represent the next generation of solar technologies, providing a competitive, high-performance, lower-carbon alternative to conventional crystalline silicon PV panels. From raw material sourcing and manufacturing through end-of-life module recycling, First Solar’s approach to technology embodies sustainability and a responsibility towards people and the planet. For more information, please visit www.firstsolar.com.

For First Solar Investors

This release contains forward-looking statements, which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to statements concerning 1) an order for approximately 1 GWDCof solar modules by Capital Power Development, LLC; 2) First Solar’s plan to invest approximately $1.1 billion in building a fourth factory in Alabama, $185 million on expanding the capacity of its existing manufacturing footprint in Ohio, and $370 million in a new R&D innovation center in Ohio; and 3) First Solar’s expectation that its annual US nameplate manufacturing capacity will expand to 10.6 GW by 2026. These forward-looking statements are often characterized by the use of words such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “seek,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “goal,” “target,” “might,” “will,” “could,” “predict,” “continue” and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events and therefore speak only as of the date of this release. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason, whether as a result of new information, future developments or otherwise. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our most recent Annual Report on Form 10-K, as supplemented by our other filings with the Securities and Exchange Commission.

Media

Reuven Proença

First Solar Media

[email protected]

Katherine Perron

Media Relations & Communications Manager

[email protected]

Investors

Robyn Remes

First Solar Investor Relations

[email protected]

Randy Mah

Director, Investor Relations

[email protected]

KEYWORDS: United States North America Arizona

INDUSTRY KEYWORDS: Semiconductor Technology Utilities Alternative Energy Energy Hardware

MEDIA:

Logo
Logo
Photo
Photo
First Solar and Capital Power Corporation announced today that Capital Power has secured its first order for approximately 1 gigawatt (GWDC) of responsibly produced, ultra-low carbon thin film solar modules. (Photo: Business Wire)